Kidney Transplant as a Treatment Option
Technical excellence and a genuine interest and concern for people are
three of the most distinguishing characteristics that describe the staff
at the Barnabas Health Renal and Pancreas Transplant Division. Add clinical
research and patient advocacy to the picture and you can begin to see
why people prefer the premier program that has served New Jersey and out-of-state
residents for more than 30 years in the field of renal transplantation.
This nationally respected team of nephrologists and surgeons, working
closely with experienced registered nurses, social workers and support
staff, offers an increasing number of transplant opportunities for people
who choose this treatment alternative, and hope to many whose medical
conditions previously prevented transplantation as an option.
Transplant recipients are experiencing an improved quality of life, independent
of dialysis and its restrictions, through living or deceased donor donation,
simultaneous pancreas-kidney, pancreas-after-kidney transplant and pediatric
kidney transplantation programs that consistently achieve outstanding
Transplant candidates meet team members, talk with transplant recipients,
and learn more about kidney transplantation at small informal educational
sessions scheduled weekly at the Barnabas Health Renal and Pancreas Transplant
Programs, located at Newark Beth Israel Medical Center and Saint Barnabas
Medical Center in Livingston. Blending the most modern technology and
resources with attentive personalized care available at two of New Jersey's
leading medical institutions, Barnabas Health Renal and Pancreas Transplant
Programs provide comprehensive support for patients and their families
throughout the process of obtaining a transplant and maintaining a healthy organ.
Newark Beth Israel Medical Center and
Saint Barnabas Medical Center offer a Bloodless Surgery Program.
The world-class Renal and Pancreas Transplant Division of Barnabas Health
is one of the world's most progressive transplant programs and one
of the largest programs among 240 in the United States. In 2014, the Division
performed 247 transplants, including 131 living donor transplants. The
Department of Transplant Research is participating in clinical drug trials
and investigating the most current anti-rejection medications available.